首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2008047

Mometasone市場：依劑型、適應症、給藥途徑、通路及地區分類。

Mometasone Furoate Market, By Dosage form, By Indication, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年03月24日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，糠酸Mometasone市場規模估計為15.826億美元，預計2033年將達到26.08億美元。預計2026年至2033年，其複合年成長率將達7.4%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	15.826億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.40%	2033年市場規模預測：	26.08億美元

莫米松福Mometasone外用製劑能有效緩解各種皮膚疾病引起的紅腫、搔癢和其他疼痛。Mometasone是一種皮質類固醇藥物，也用於治療氣喘，並且能有效治療方法各種皮膚過敏和其他過敏性疾病，例如花粉症和過敏性鼻炎。

市場動態

預計氣喘在全球的盛行率將持續上升，並在預測期內顯著成長。例如，根據世界衛生組織（世衛組織）的數據，2019年有45.5萬人死於氣喘，全球約有2.62億人受氣喘影響。氣喘的誤診率和治療效果普遍不佳，尤其是在中低收入國家。在最嚴重的情況下，氣喘甚至可能致命。

預計在預測期內，市場相關人員新產品的上市和核准增加將推動全球糠酸Mometasone市場成長。例如，2017年4月，總部位於美國的上市學名藥和專科製藥公司Amneel Pharmaceuticals LLC推出了Mometasone鼻噴霧該公司首款噴霧劑型藥品。 Nasonex是Mometasone莫米鬆的治療等效物，每次噴霧濃度為50微克。

預計在預測期內，與糠酸Mometasone相關的研發活動的增加將推動市場成長。例如，根據2019年12月發表在醫學期刊《Medicine》上的報導，一項在中國進行的研究旨在檢驗局部應用Mometasone對降低頭頸部鱗狀細胞癌（HNSCC）患者急性放射性皮膚炎（ARD）的療效。研究將患者分為兩組：試驗組和對照組。試驗組患者從放射治療開始至患側皮膚出現急性放射性皮膚炎（ARD）病變期間，每日一次接受Mometasone治療；而對照組患者未接受任何治療。該研究表明，高劑量放射治療後局部應用Mometasone可以預防急性放射性皮膚炎（ARD）。

本研究的主要特點。

本報告對預測期間（2022-2030 年）內全球糠酸Mometasone市場的規模進行了詳細分析，以 2021 年為基準年。
本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要企業採取的競爭策略的重要見解。
本報告根據以下參數分析了全球糠酸Mometasone市場的主要企業：公司概況、財務績效、產品系列、企業發展區域、分銷策略、主要發展和策略以及未來計劃。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊可以就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
本報告面向該產業的各類相關人員，包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
透過對全球糠酸Mometasone市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第9章競爭情勢

公司簡介
- Cipla
- Teva Pharmaceuticals
- Glenmark Pharmaceuticals
- AdvaCare Pharma
- Medlab Pharmaceuticals Private Limited
- Dermocare Laboratories
- Iva Healthcare Private Limited
- Unilab Chemicals &Pharmaceuticals Pvt Ltd
- Organon group of companies
- Cosette Pharmaceuticals
- Taro Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals.

第10章

調查方法
關於本公司
聯繫類型

簡介目錄

Product Code: CMI5198

Mometasone Furoate Market is estimated to be valued at USD 1,582.6 Mn in 2026 and is expected to reach USD 2,608.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,582.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.40%	2033 Value Projection:	USD 2,608.0 Mn

Mometasone furoate topical is effective at reducing the redness, itching, swelling, and other pain caused by several skin conditions. Mometasone furoate is a corticosteroid drug also used to treat asthma and it is an effective treatment for a variety of skin allergies as well as other allergic conditions like hay fever and allergic rhinitis.

Market Dynamics

Increasing prevalence of asthma worldwide is expected to witness significant growth in forecast period. For instance, according to the World Health Organization (WHO), in 2019, 455 000 individuals died from asthma and an estimated 262 million people were affected by asthma worldwide. Asthma is widely misdiagnosed and poorly managed, particularly in low- and middle-income countries. In most severe cases, asthma can be fatal.

Increasing product launches and approvals by market players are expected to drive growth of the global mometasone furoate market over the forecast period. For instance, in April 2017, Amneal Pharmaceuticals LLC, a U.S.-based, publicly traded generics and specialty pharmaceutical company launched Mometasone furoate nasal spray, the first pharmaceutical product that Amneal Pharmaceuticals LLC had produced in spray form. Nasonex is therapeutic equivalent of mometasone furoate and is offered in 50 mcg/spray strength.

Increasing research and development activities related to mometasone furoate are expected to drive growth of market over the forecast period. For instance, according to an article published in Medicine, medical journal, in December 2019, a study was performed on patients with head and neck squamous cell carcinoma (HNSCC) to check efficacy of local application of mometasone furoate in reducing acute radiation dermatitis (ARD) in China. Patients were divided into two groups, test groups and control groups. The patients in test groups were given mometasone furoate once daily from the start of their radiotherapy until the test side skin acquired ARD lesions, and patients in control groups, were given no treatment at all. The study showed that, mometasone furoate inunction after high dose radiotherapy can prevent acute radiation dermatitis (ARD).

Key features of the study

This report provides an in-depth analysis of the global mometasone furoate market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global mometasone furoate market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include include Cipla, Teva Pharmaceuticals, Glenmark Pharmaceuticals, AdvaCare Pharma, Medlab Pharmaceuticals Private Limited, Dermocare Laboratories, Iva Healthcare Private Limited, Unilab Chemicals & Pharmaceuticals Pvt Ltd, Organon group of companies, Cosette Pharmaceuticals, Taro Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make an informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global mometasone furoate market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global mometasone furoate market

Market Segmentation

Global Mometasone Furoate Market, By Dosage form
- Nasal Spray
- Cream
- Ointment
- Inhalers
- Others (Topical Solutions, etc.)
Global Mometasone Furoate Market, By Indication
- Inflammatory Skin Disorders
- Asthma
- Allergic rhinitis
- Others (Hay Fever, etc.)
Global Mometasone Furoate Market, By Route of Administration
- Nasal Administration
- Topical
- Oral
Global Mometasone Furoate Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Mometasone Furoate Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Global Mometasone Furoate Market, Key Players
- Cipla
- Teva Pharmaceuticals
- Glenmark Pharmaceuticals
- AdvaCare Pharma
- Medlab Pharmaceuticals Private Limited
- Dermocare Laboratories
- Iva Healthcare Private Limited
- Unilab Chemicals & Pharmaceuticals Pvt Ltd
- Organon group of companies
- Cosette Pharmaceuticals
- Taro Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Dosage form
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Porter's Analysis
Industry Trends
Key Highlights
Epidemiology
Reimbursement Scenario
Regulatory Scenario
Product Launch and Approvals
Acquisition and Collaboration Scenario

4. Global Mometasone Furoate Market, By Dosage Form, 2026-2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Nasal spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Cream
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Ointment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Mometasone Furoate Market, By Indication, 2026-2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Inflammatory skin disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Allergic rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Mometasone Furoate Market, By Route of Administration, 2026-2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global Mometasone Furoate Market, By Distribution Channel, 2026-2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

8. Global Mometasone Furoate Market, By Region, 2026-2033 (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
North America
- Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
- Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
- Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
- Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
- Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
- Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country, 2026-2033 (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
- Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
- Market Size and Forecast, By Country/Region, 2026-2033 (USD Mn)
  - South Africa
  - Central Africa
  - North Africa

9. Competitive Landscape

Company Profiles
- Cipla
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Teva Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Glenmark Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- AdvaCare Pharma
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Medlab Pharmaceuticals Private Limited
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Dermocare Laboratories
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Iva Healthcare Private Limited
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Unilab Chemicals & Pharmaceuticals Pvt Ltd
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Organon group of companies
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Cosette Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Taro Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Hikma Pharmaceuticals.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
  - Analyst Views